ABPO · Abpro Holdings, Inc. · Executive Compensation
$0.40
+0.04 (+12.59%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, based on the considerations discussed above, management has concluded there is substantial doubt as to the Company's ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.36M
Shares
5.90M
Volume · Oct 21
20.05K
Avg daily vol (3M)
11.27K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ian Chan | Former Chief Executive Officer | $521,754 |
| Robert Markelewicz | Chief Medical Officer | $483,577 |
| Christian Zapf | Former Senior Vice President of Corporate Development and Former General Counsel of Abpro Corporation | $258,433 |
| Miles Suk | Chief Executive Officer and Chairman | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ian Chan | Former Chief Executive Officer | $772,917 |
| Robert Markelewicz | Chief Medical Officer | $546,118 |
| Christian Zapf | Former Senior Vice President of Corporate Development and Former General Counsel of Abpro Corporation | $338,337 |
| Miles Suk | Chief Executive Officer and Chairman | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Miles Suk | Chairman of the Board of Directors | Resigned | 2026-09-01 |
| M. Fatih Karatas | Interim Chief Executive Officer | Appointed | 2026-08-25 |
| Miles Suk | Chief Executive Officer | Resigned | 2026-08-25 |
| M. Fatih Karatas | Class II director | Appointed | 2026-02-11 |
| Mary Gunn | Class II director | Appointed | 2026-02-11 |
| Sooyoung Lee | Board | Resigned | 2026-02-11 |
| Anthony D. Eisenberg | Board | Resigned | 2026-02-11 |
| Sooyoung Lee | Board | Resigned | 2026-02-03 |
| Anthony D. Eisenberg | Board | Resigned | 2026-02-03 |
| Byung-Hak Yoon | Class I director | Appointed | 2026-01-23 |
| Ian McDonald | member of the Board of Directors | Resigned | 2026-01-23 |
| Robert J. Markelewicz, Jr. | Chief Medical Officer | Terminated | 2025-10-02 |
| Jin Wook (Miles) Suk | Chief Executive Officer | Appointed | 2025-07-24 |
| Ian Chan | Chief Executive Officer and principal executive officer | Terminated | 2025-03-07 |
| Shahraab Ahmad | Chief Financial Officer | Resigned | 2024-11-29 |
| Ian McDonald | Director | Appointed | 2024-11-26 |
| Anthony D. Eisenberg | Director | Appointed | 2024-11-26 |
| Soo Young Lee | Director | Appointed | 2024-11-26 |
| Jin Wook (Miles) Suk | Co-Chief Executive Officer, Director and Chairman of the Board | Appointed | 2024-11-26 |
| Shahraab Ahmad | Chief Financial Officer | Appointed | 2024-11-26 |
| Robert J. Markelewicz, Jr., M.D., M.M.Sc. | Chief Medical Officer | Appointed | 2024-11-26 |
| Ian Chan | Chief Executive Officer and Director | Appointed | 2024-11-26 |
| Curtis Collar | Board and the Audit Committee of the Board | Appointed | 2023-11-07 |
| Iqbaljit Kahlon | Board of Directors | Resigned | 2023-11-07 |
Leadership
- Ian Chan CEO, Board Member
- Jin Wook (Miles) Suk CEO, Chairman
- M. Fatih Karatas CEO, Board Member
- Shahraab Ahmad CFO
- Christian Zapf General Counsel
- Anthony D. Eisenberg Board Member
- Byung-Hak Yoon Board Member
- Curtis Collar Board Member
- Ian McDonald Board Member
- Mary Gunn Board Member
- Soo Young Lee Board Member